Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia

被引:67
作者
Jabbar, MA [1 ]
Zuhri-Yafi, MI [1 ]
Larrea, J [1 ]
机构
[1] Michigan State Univ, Dept Pediat, Hurley Med Ctr, Flint, MI 48502 USA
关键词
hypertriglyceridemia; fish oil; insulin; gemfibrozil;
D O I
10.1080/07315724.1998.10718794
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: To compare the short and long term effectiveness of fish oil, insulin, and gemfibrozil in a non-diabetic patient with severe hypertriglyceridemia. Method: An adolescent male with hypertriglyceridemia (triglyceride level 4575 mg/dl) and abdominal pain was treated with the goal of immediate reduction and maintenance of triglyceride (TG) level below 1000 mg/dl. Fish oil, insulin and gemfibrozil were administered sequentially, in separate time blocks, for a duration of 3, 6, and 6 months, respectively. Results: Fish oil took several weeks to lower TG level, and patient compliance during 3 months of therapy was inadequate. Insulin was effective in immediately lowering the TG level, but was unable to maintain the level below 1000 mg/dl. Gemfibrozil was ineffective in achieving the immediate reduction of TG level; however, it was adequate in maintaining the desired level in the long-term and patient compliance was better than with the fish oil. Conclusion: In patients with risk of pancreatitis due to severe hypertriglyceridemia, immediate reduction of the triglyceride level is achievable by using a single dose of regular insulin (0.1 unit/kg, subcutaneous) while long-term maintenance therapy can be provided by gemfibrozil.
引用
收藏
页码:458 / 461
页数:4
相关论文
共 13 条
[1]  
*AM AC PED, 1992, COMMITTEE NUTR, V90, P469
[2]   PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART-DISEASE - THE EPIDEMIOLOGIC EVIDENCE AND BEYOND [J].
AUSTIN, MA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (02) :249-259
[3]   Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease [J].
Belluzzi, A ;
Brignola, C ;
Campieri, M ;
Pera, A ;
Boschi, S ;
Miglioli, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) :1557-1560
[4]   Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene [J].
Benlian, P ;
DeGennes, JL ;
Foubert, L ;
Zhang, HF ;
Gagne, SE ;
Hayden, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :848-854
[5]  
BIERMAN EI, 1992, WILLIAMS TXB ENDICRO, P1380
[6]  
BRUNZELL JD, 1995, METABOLIC MOL BASIS, P1916
[7]   SEVERE HYPERTRIGLYCERIDEMIA - ROLE OF FAMILIAL AND ACQUIRED DISORDERS [J].
CHAIT, A ;
BRUNZELL, JD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (03) :209-214
[8]  
DONNELLY SM, 1992, J AM SOC NEPHROL, V2, P1634
[9]   HYPERLIPOPROTEINEMIA AND PANCREATITIS [J].
FARMER, RG ;
WINKELMAN, EI ;
BROWN, HB ;
LEWIS, LA .
AMERICAN JOURNAL OF MEDICINE, 1973, 54 (02) :161-165
[10]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245